the regimen consisted of mitoxantrone ( m ) 10 mg/m2 i.v . days 4-8 , cytosine arabinoside ( a ) 100 mg/m2 continuous infusion days 1-8 , and etoposide ( vp-16 ) ( v ) 100-120 mg/m2 i.v . days 4-8 ( mav protocol ) for relapsed and refractory aml .
C0015133
etoposide
C0023467
aml